InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: J-Belfort post# 34229

Monday, 01/25/2021 7:00:51 PM

Monday, January 25, 2021 7:00:51 PM

Post# of 44690
RLF data is due presently and this other Dr reddy trial has just been approved to start.
RLF owns the RLF-100* patent for formulations in the US and several other countries. India is usually an outsider itself and manufactured Remdesivir without license for use in their own country. Currently there is plenty of demand in the countries the patent protection includes.

ACER is perfect for RLF. It would get us out from under the NRX thumb and their issues. The recent new hires at RLf seems to prove JB's point that this is not an unplanned fling and that there are many possibilities that can happen beyond the basic agreement.
Ruf, I hope you know that Aviptadil was an ED drug before repurposing for COVID/lung issues, so why not the drug from Acer that is for a urinary issue too?



*(by whever brand name)